Nathaniel S. Gardiner
2016
In 2016, Nathaniel S. Gardiner earned a total compensation of $1.1M as Senior Vice President and General Counsel at Enanta Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $116,764 |
|---|---|
| Option Awards | $505,986 |
| Salary | $353,403 |
| Stock Awards | $94,175 |
| Other | $15,857 |
| Total | $1,086,185 |
Gardiner received $506K in option awards, accounting for 47% of the total pay in 2016.
Gardiner also received $116.8K in non-equity incentive plan, $353.4K in salary, $94.2K in stock awards and $15.9K in other compensation.
Rankings
In 2016, Nathaniel S. Gardiner's compensation ranked 7,846th out of 14,075 executives tracked by ExecPay. In other words, Gardiner earned more than 44.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,846 out of 14,075 | 44th |
Division Manufacturing | 2,985 out of 5,489 | 46th |
Major group Chemicals And Allied Products | 990 out of 1,895 | 48th |
Industry group Drugs | 767 out of 1,538 | 50th |
Industry Pharmaceutical Preparations | 610 out of 1,176 | 48th |
Source: SEC filing on January 18, 2019.
Gardiner's colleagues
We found four more compensation records of executives who worked with Nathaniel S. Gardiner at Enanta Pharmaceuticals in 2016.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019